Literature DB >> 15118129

Infectious diseases. Mounting lab accidents raise SARS fears.

Dennis Normile.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15118129     DOI: 10.1126/science.304.5671.659

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  38 in total

Review 1.  Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.

Authors:  Wenhui Li; Swee-Kee Wong; Fang Li; Jens H Kuhn; I-Chueh Huang; Hyeryun Choe; Michael Farzan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Stigmatization of newly emerging infectious diseases: AIDS and SARS.

Authors:  Don C Des Jarlais; Sandro Galea; Melissa Tracy; Susan Tross; David Vlahov
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

Review 3.  Insights from the association of SARS-CoV S-protein with its receptor, ACE2.

Authors:  Wenhui Li; Hyeryun Choe; Michael Farzan
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

Authors:  Zhiwei Chen; Linqi Zhang; Chuan Qin; Lei Ba; Christopher E Yi; Fengwen Zhang; Qiang Wei; Tian He; Wenjie Yu; Jian Yu; Hong Gao; Xinming Tu; Agegnehu Gettie; Michael Farzan; Kwok-Yung Yuen; David D Ho
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens.

Authors:  Joshua M DiNapoli; Alexander Kotelkin; Lijuan Yang; Subbiah Elankumaran; Brian R Murphy; Siba K Samal; Peter L Collins; Alexander Bukreyev
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

Review 6.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

7.  Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models.

Authors:  Renaud Burrer; Benjamin W Neuman; Joey P C Ting; David A Stein; Hong M Moulton; Patrick L Iversen; Peter Kuhn; Michael J Buchmeier
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

8.  A rapid point of care immunoswab assay for SARS-CoV detection.

Authors:  Sriram Kammila; Dipankar Das; Pravin K Bhatnagar; Hoon H Sunwoo; Gustavo Zayas-Zamora; Malcolm King; Mavanur R Suresh
Journal:  J Virol Methods       Date:  2008-07-11       Impact factor: 2.014

Review 9.  The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Authors:  Lanying Du; Yuxian He; Yusen Zhou; Shuwen Liu; Bo-Jian Zheng; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

10.  Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.

Authors:  Yanbo Lv; Zhihua Ruan; Li Wang; Bing Ni; Yuzhang Wu
Journal:  BMC Immunol       Date:  2009-12-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.